Skip to main content
Erschienen in: Endocrine 2/2015

01.11.2015 | Original Article

Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes

verfasst von: Eun Sook Kim, Sung Won Lee, Eun Young Mo, Sung Dae Moon, Je Ho Han

Erschienen in: Endocrine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Several studies have suggested that bilirubin, a potent innate antioxidant, plays a protective role against cardiovascular and microvascular disease. This study investigated the association between serum concentrations of total bilirubin (TB) and the presence of diabetic peripheral neuropathy (DPN) in Korean diabetic patients. This cross-sectional study involved 1207 patients aged more than 30 years with type 2 diabetes. DPN was assessed according to clinical symptoms and physical examinations using Michigan Neuropathy Screening Instrument examination score, 10-g monofilament sensation, and current perception threshold. The subjects were stratified into gender-specific tertiles based on TB values, and the relationship between the TB values and DPN was analyzed. Compared with patients within the lowest TB tertile, those with higher TB levels consisted of patients with shorter duration of diabetes, lower HbA1c, better renal function, and less autonomic neuropathy, retinopathy, and albuminuria. Serum TB levels were inversely associated with DPN. In multivariate analysis for the development of DPN after adjusting for potential confounding factors including retinopathy, albuminuria, and autonomic neuropathy, the TB levels were inversely associated with the presence of DPN, both as a continuous variable [odds ratio (OR) per log standard deviation (SD) 0.79; 95 % confidence interval (CI) 0.65–0.97; P = 0.022] and when categorized in tertiles (the highest vs. the lowest tertile; OR 0.63; 95 % CI 0.40–0.99; P = 0.046). Low serum bilirubin levels are significantly associated with DPN, independently of classic risk factors and other microvascular complications. Further investigation is necessary to determine whether serum bilirubin has a prognostic significance on DPN.
Literatur
2.
Zurück zum Zitat S. Tesfaye, A.J.M. Boulton, P. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293 (2010)PubMedCentralCrossRefPubMed S. Tesfaye, A.J.M. Boulton, P. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293 (2010)PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat M. Brownlee, The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615–1625 (2005)CrossRefPubMed M. Brownlee, The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615–1625 (2005)CrossRefPubMed
4.
Zurück zum Zitat A.J. Boulton, F.A. Gries, J.A. Jervell, Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet. Med. 15, 508–514 (1998)CrossRefPubMed A.J. Boulton, F.A. Gries, J.A. Jervell, Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet. Med. 15, 508–514 (1998)CrossRefPubMed
5.
Zurück zum Zitat R. Stocker, Y. Yamamoto, A.F. McDonagh, A.N. Glazer, B.N. Ames, Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043–1046 (1987)CrossRefPubMed R. Stocker, Y. Yamamoto, A.F. McDonagh, A.N. Glazer, B.N. Ames, Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043–1046 (1987)CrossRefPubMed
6.
Zurück zum Zitat H. Kimm, J. Yun, J. Jo, S. Jee, Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 40, 3422–3427 (2009)CrossRefPubMed H. Kimm, J. Yun, J. Jo, S. Jee, Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 40, 3422–3427 (2009)CrossRefPubMed
7.
Zurück zum Zitat T. Perlstein, R. Pande, J. Beckman, M. Creager, Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 166–172 (2008)CrossRefPubMed T. Perlstein, R. Pande, J. Beckman, M. Creager, Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 166–172 (2008)CrossRefPubMed
8.
Zurück zum Zitat P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, R.R. Williams, Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16, 250–255 (1996). doi:10.1161/01.atv.16.2.250 CrossRefPubMed P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, R.R. Williams, Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16, 250–255 (1996). doi:10.​1161/​01.​atv.​16.​2.​250 CrossRefPubMed
9.
Zurück zum Zitat L. Horsfall, I. Nazareth, I. Petersen, Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126, 2556–2564 (2012)CrossRefPubMed L. Horsfall, I. Nazareth, I. Petersen, Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126, 2556–2564 (2012)CrossRefPubMed
10.
Zurück zum Zitat E.L. Feldman, M.J. Stevens, P.K. Thomas, M.B. Brown, N. Canal, D.A. Greene, A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17, 1281–1289 (1994)CrossRefPubMed E.L. Feldman, M.J. Stevens, P.K. Thomas, M.B. Brown, N. Canal, D.A. Greene, A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17, 1281–1289 (1994)CrossRefPubMed
11.
Zurück zum Zitat A.N. Paisley, C.A. Abbott, C.H.M. van Schie, A.J.M. Boulton, A comparison of the neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabet. Med. 19, 400–405 (2002)CrossRefPubMed A.N. Paisley, C.A. Abbott, C.H.M. van Schie, A.J.M. Boulton, A comparison of the neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabet. Med. 19, 400–405 (2002)CrossRefPubMed
12.
Zurück zum Zitat L.A. Stevens, J. Coresh, T. Greene, A.S. Levey, Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473–2483 (2006)CrossRefPubMed L.A. Stevens, J. Coresh, T. Greene, A.S. Levey, Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473–2483 (2006)CrossRefPubMed
13.
Zurück zum Zitat V. Viswanathan, D. Prasad, S. Chamukuttan, A. Ramachandran, High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res. Clin. Pract. 48, 211–216 (2000)CrossRefPubMed V. Viswanathan, D. Prasad, S. Chamukuttan, A. Ramachandran, High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res. Clin. Pract. 48, 211–216 (2000)CrossRefPubMed
14.
Zurück zum Zitat T. Inoguchi, S. Sasaki, K. Kobayashi, R. Takayanagi, T. Yamada, Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA J. Am. Med. Assoc. 298, 1398–1400 (2007)CrossRef T. Inoguchi, S. Sasaki, K. Kobayashi, R. Takayanagi, T. Yamada, Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA J. Am. Med. Assoc. 298, 1398–1400 (2007)CrossRef
15.
Zurück zum Zitat M. Yasuda, Y. Kiyohara, J. Wang, S. Arakawa, K. Yonemoto, Y. Doi, T. Ninomiya, T. Ishibashi, High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology 118, 1423–1428 (2011)PubMed M. Yasuda, Y. Kiyohara, J. Wang, S. Arakawa, K. Yonemoto, Y. Doi, T. Ninomiya, T. Ishibashi, High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology 118, 1423–1428 (2011)PubMed
16.
Zurück zum Zitat M. Fukui, M. Tanaka, E. Shiraishi, I. Harusato, H. Hosoda, M. Asano, G. Hasegawa, N. Nakamura, Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 74, 1197–1201 (2008)CrossRefPubMed M. Fukui, M. Tanaka, E. Shiraishi, I. Harusato, H. Hosoda, M. Asano, G. Hasegawa, N. Nakamura, Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 74, 1197–1201 (2008)CrossRefPubMed
17.
Zurück zum Zitat J.O. Chung, D.H. Cho, D.J. Chung, M.Y. Chung, Physiological serum bilirubin concentrations are inversely associated with the prevalence of cardiovascular autonomic neuropathy in patients with Type 2 diabetes. Diabet. Med. (2013). doi:10.1111/dme.12338 PubMed J.O. Chung, D.H. Cho, D.J. Chung, M.Y. Chung, Physiological serum bilirubin concentrations are inversely associated with the prevalence of cardiovascular autonomic neuropathy in patients with Type 2 diabetes. Diabet. Med. (2013). doi:10.​1111/​dme.​12338 PubMed
18.
Zurück zum Zitat C. Jung, M. Lee, Y. Kang, J. Hwang, J. Jang, J. Leem, J.-Y. Park, H.-K. Kim, W. Lee, Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study. Metab. Clin. Exp. 63, 87–93 (2014)CrossRefPubMed C. Jung, M. Lee, Y. Kang, J. Hwang, J. Jang, J. Leem, J.-Y. Park, H.-K. Kim, W. Lee, Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study. Metab. Clin. Exp. 63, 87–93 (2014)CrossRefPubMed
19.
Zurück zum Zitat I. Riphagen, P. Deetman, S.J.L. Bakker, G. Navis, M. Cooper, J. Lewis, D. de Zeeuw, H. Lambers Heerspink, Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT. Diabetes 63, 2845–2853 (2014)CrossRefPubMed I. Riphagen, P. Deetman, S.J.L. Bakker, G. Navis, M. Cooper, J. Lewis, D. de Zeeuw, H. Lambers Heerspink, Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT. Diabetes 63, 2845–2853 (2014)CrossRefPubMed
20.
Zurück zum Zitat K.H. Chan, R.L. O’Connell, D.R. Sullivan, L.S. Hoffmann, K. Rajamani, M. Whiting, M.W. Donoghoe, M. Vanhala, A. Hamer, B. Yu, R. Stocker, M.K.C. Ng, A.C. Keech, Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 56, 724–736 (2013)CrossRefPubMed K.H. Chan, R.L. O’Connell, D.R. Sullivan, L.S. Hoffmann, K. Rajamani, M. Whiting, M.W. Donoghoe, M. Vanhala, A. Hamer, B. Yu, R. Stocker, M.K.C. Ng, A.C. Keech, Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 56, 724–736 (2013)CrossRefPubMed
21.
Zurück zum Zitat S. Yagihashi, H. Mizukami, K. Sugimoto, Mechanism of diabetic neuropathy: where are we now and where to go? J. Diabetes Investig. 2, 18–32 (2011)PubMedCentralCrossRefPubMed S. Yagihashi, H. Mizukami, K. Sugimoto, Mechanism of diabetic neuropathy: where are we now and where to go? J. Diabetes Investig. 2, 18–32 (2011)PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat C. Petrich, U. Gobel, Letter: idiopathic hyperbilirubinemia and phototherapy—evidence suggesting a decreased incidence of kernicterus. Pediatrics 54, 654–655 (1974)PubMed C. Petrich, U. Gobel, Letter: idiopathic hyperbilirubinemia and phototherapy—evidence suggesting a decreased incidence of kernicterus. Pediatrics 54, 654–655 (1974)PubMed
23.
Zurück zum Zitat J.Y. Kwak, K. Takeshige, B.S. Cheung, S. Minakami, Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim. Biophys. Acta 1076, 369–373 (1991)CrossRefPubMed J.Y. Kwak, K. Takeshige, B.S. Cheung, S. Minakami, Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim. Biophys. Acta 1076, 369–373 (1991)CrossRefPubMed
24.
25.
Zurück zum Zitat N. Papanas, N. Katsiki, K. Papatheodorou, M. Demetriou, D. Papazoglou, T. Gioka, E. Maltezos, Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62, 291–295 (2011)CrossRefPubMed N. Papanas, N. Katsiki, K. Papatheodorou, M. Demetriou, D. Papazoglou, T. Gioka, E. Maltezos, Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62, 291–295 (2011)CrossRefPubMed
26.
Zurück zum Zitat N. Papanas, M. Demetriou, N. Katsiki, K. Papatheodorou, D. Papazoglou, T. Gioka, S. Kotsiou, E. Maltezos, D.P. Mikhailidis, Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus. Exp. Diabetes Res. 2011, 346051 (2011). doi:10.1155/2011/346051 PubMedCentralCrossRefPubMed N. Papanas, M. Demetriou, N. Katsiki, K. Papatheodorou, D. Papazoglou, T. Gioka, S. Kotsiou, E. Maltezos, D.P. Mikhailidis, Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus. Exp. Diabetes Res. 2011, 346051 (2011). doi:10.​1155/​2011/​346051 PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat E.D. Petronella, J.L.B. Stephan, P.F.D. Robin, High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc. Diabetol. 12, 166 (2013). doi:10.1186/1475-2840-12-166 CrossRef E.D. Petronella, J.L.B. Stephan, P.F.D. Robin, High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc. Diabetol. 12, 166 (2013). doi:10.​1186/​1475-2840-12-166 CrossRef
28.
Zurück zum Zitat H.J. Hwang, S.W. Lee, S.H. Kim, Relationship between bilirubin and C-reactive protein. Clin. Chem. Lab. Med. 49, 1823–1828 (2011)PubMed H.J. Hwang, S.W. Lee, S.H. Kim, Relationship between bilirubin and C-reactive protein. Clin. Chem. Lab. Med. 49, 1823–1828 (2011)PubMed
30.
Zurück zum Zitat Y.-H. Chen, L.-Y. Chau, J.-W. Chen, S.-J. Lin, Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31, 1615–1620 (2008). doi:10.2337/dc07-2126 PubMedCentralCrossRefPubMed Y.-H. Chen, L.-Y. Chau, J.-W. Chen, S.-J. Lin, Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31, 1615–1620 (2008). doi:10.​2337/​dc07-2126 PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat P.J. Bosma, J.R. Chowdhury, C. Bakker, S. Gantla, A. de Boer, B.A. Oostra, D. Lindhout, G.N. Tytgat, P.L. Jansen, R.P. Oude Elferink, The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. New Engl. J Med. 333, 1171–1175 (1995)CrossRefPubMed P.J. Bosma, J.R. Chowdhury, C. Bakker, S. Gantla, A. de Boer, B.A. Oostra, D. Lindhout, G.N. Tytgat, P.L. Jansen, R.P. Oude Elferink, The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. New Engl. J Med. 333, 1171–1175 (1995)CrossRefPubMed
33.
Zurück zum Zitat C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273–279 (2011)CrossRefPubMed C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273–279 (2011)CrossRefPubMed
34.
35.
Zurück zum Zitat C. Gazzaruso, A. Coppola, C. Falcone, C. Luppi, T. Montalcini, E. Baffero, P. Gallotti, A. Pujia, S. Solerte, G. Pelissero, A. Giustina, Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36, 1720–1725 (2013)PubMedCentralCrossRefPubMed C. Gazzaruso, A. Coppola, C. Falcone, C. Luppi, T. Montalcini, E. Baffero, P. Gallotti, A. Pujia, S. Solerte, G. Pelissero, A. Giustina, Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36, 1720–1725 (2013)PubMedCentralCrossRefPubMed
Metadaten
Titel
Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes
verfasst von
Eun Sook Kim
Sung Won Lee
Eun Young Mo
Sung Dae Moon
Je Ho Han
Publikationsdatum
01.11.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0583-0

Weitere Artikel der Ausgabe 2/2015

Endocrine 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.